Lymna-DF-amide 5 is part of a suite of molluscan neuropeptides supporting studies of feeding and locomotor regulation. Its structure permits examination of RFamide-driven receptor dynamics. Researchers apply it to analyze conformational variation within neuroactive peptide families. The peptide aids comparative mapping of gastropod neural signaling.
CAT No: L14005
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.